Vini Gautam

Vini Gautam

Auto-generated profile, based on publicly available information

Vini Gautam

Department of Biomedical Engineering Graeme Clark Institute The University of Melbourne Parkville Victoria Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Biomaterials
Verified
Journal Article
Closed access
CHChao Hu
Chao Hu
DADeepu Ashok
Deepu Ashok
David NisbetDavid Nisbet
David Nisbet
VGVini Gautam
Vini Gautam

4 May 2017 in Nano Letters
Verified
Journal Article
Closed access
VGVini Gautam
Vini Gautam
SNShagufta Naureen
Shagufta Naureen
NSNaeem Shahid
Naeem Shahid
QGQian Gao
Qian Gao
YWYi Wang
Yi Wang
VDVincent Daria
Vincent Daria

5 June 2024 in Nature Reviews Bioengineering
Verified
Journal Article
Closed access
PDF file
BSBram Servais
Bram Servais
NMNegar Mahmoudi
Negar Mahmoudi
VGVini Gautam
Vini Gautam
WTWei Tong
Wei Tong
MIMichael R. Ibbotson
Michael R. Ibbotson
David J. CollinsDavid J. Collins
David J. Collins

13 April 2020 in The Neuroscientist
Verified
Journal Article
Open access
PDF file
LOLezanne Ooi
Lezanne Ooi
MDMirella Dottori
Mirella Dottori
ACAnthony L Cook
Anthony L Cook
MEMartin Engel
Martin Engel
VGVini Gautam
Vini Gautam
RWRobert Williamson
Robert Williamson
Because our beliefs regarding our individuality, autonomy, and personhood are intimately bound up with our brains, there is a public fascination with cerebral organoids, the “mini-brain,” the “brain in a dish”. At the same time, the ethical issues around organoids are only now being explored. What are the prospects of using human cerebral organoids to better understand, treat, or prevent dementia? Will human organoids represent an improvement on the current, less-than-satisfactory, animal models? When considering these questions, two major issues arise. One is the general challenge associated with using any stem cell–generated preparation for in vitro modelling (challenges amplified when using organoids compared with simpler cell culture systems). The other relates to complexities associated with defining and understanding what we mean by the term “dementia.” We discuss 10 puzzles, issues, and stumbling blocks to watch for in the quest to model “dementia in a dish.”

6 August 2020 in Neurophotonics
Verified
Journal Article
Open access
PDF file
LHLiam Hanlon
Liam Hanlon
VGVini Gautam
Vini Gautam
JWJames D. A. Wood
James D. A. Wood
PRPrithvi Reddy
Prithvi Reddy
MBMichael S. J. Barson
Michael S. J. Barson
MDMarcus W. Doherty
Marcus W. Doherty
Probing new frontiers in neuronal electrophysiology is the key to understanding how the brain works. It is becoming clearer that, to fully understand neuron excitability, there are a variety of requirements that must be met. These requirements can be presented in four major areas. The first is millisecond or submillisecond temporal resolution, which allows for the measurement of action potential (AP) changes over fast timescales.1 The second is nanoscale resolution across a field of view that is large enough to compass multiple neurons in a network.1 This enables the imaging of individual neuron compartments, such as dendritic spines.2 Third, the sensitivity of the probe must be exceptional, a sensor must be able to resolve millivolt changes in potential within submillisecond timescales to sense the smallest signals produced by neurons.3 Finally, the last major requirements are the compatibility and stability of the sensor, which should enable the sensor to probe a neuron without altering its behavior and make many measurements without the sensor failing or having toxic effects on the neuron. These requirements allow for imaging of neuron changes over a long period of time, which is important for the study of neuroplastic effects.4

28 September 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Open access
HTHao Nguyen Tran
Hao Nguyen Tran
VGVini Gautam
Vini Gautam
Brain organoids are powerful experimental models to study fundamental neurodevelopmental processes and the pathology of neurological disorders. Brain organoids can now be generated from human-induced pluripotent stem cells, which pave the way for using them to investigate effective therapies for various neurodegenerative disorders and diseases. However, brain organoids possess complex cellular architecture, various unknown functionalities, and a lack of vascular networks, which have limited their use in biomedicine and clinical research. Micro/nanoscale devices and technologies can help overcome these limitations. This review critically examines recently developed micro/nano devices for integration with brain organoids. The review focuses on devices designed to achieve several key aims: to improve methodologies for in vitro culture; to enable electro-physiological recordings from organoids; to screen drugs for chemotherapy and new treatments; to understand the effects of psychoactive drugs; and to enable development of vascular networks in organoids. Along with the specific device features and their relevance for these applications, we also discuss the current challenges to overcome and future strategies to advance the use of brain organoids in clinical research. The interdisciplinary convergence of brain organoids research with materials science, device engineering, neuroscience, and stem cell biology holds remarkable potential for replicating the human brain in vitro. Micro/nano devices are an important part of realizing this potential that will afford both fundamental insights into the mechanisms underlying brain function and a pathway for developing novel treatments for neurophysiological and neurodegenerative disorders.